Inflammation drives nitric oxide synthase 2 expression by Î³Î´ T cells and affects the balance between melanoma and vitiligo associated melanoma.

Douguet, Laetitia; Bod, Lloyd; Labarthe, Laura; Lengagne, Renée; Kato, Masashi; Couillin, Isabelle; Prévost-Blondel, Armelle

Douguet, Laetitia; Bod, Lloyd; Labarthe, Laura; Lengagne, Renée; Kato, Masashi; Couillin, Isabelle; Prévost-Blondel, Armelle.

Afiliação

Douguet L; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Bod L; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.
Labarthe L; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Lengagne R; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Kato M; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.
Couillin I; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Prévost-Blondel A; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.

Oncoimmunology ; 7(9): e1484979, 2018.

Article em En | MEDLINE | ID: mdl-30228955

Palavras-chave

NOS2; interleukin 1ß; interleukin 6; melanoma; pro-tumorogenic Î³Î´ T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google